申请人:Olsson Roger
公开号:US20090176837A1
公开(公告)日:2009-07-09
Disclosed herein are novel compounds with activity at RARβ 2 receptors. Further disclosed are the use of such compounds for treatment of or to alleviate symptoms of cancer, neurological disorders such as memory deficits and schizophrenia, neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, inflammatory disorders such as psoriasis and rheumatoid arthritis, eye disorders and depression.
本文揭示了具有对RARβ 2受体活性的新化合物。进一步揭示了这些化合物的用途,用于治疗或缓解癌症、神经系统疾病(如记忆障碍和精神分裂症)、神经退行性疾病(如帕金森病和阿尔茨海默病)、炎症性疾病(如银屑病和类风湿性关节炎)、眼部疾病和抑郁症状。